{"database": "openregs", "table": "documents", "rows": [["FDA-2021-N-0874-0089", "FDA", "FDA-2021-N-0874", "September 21, 2023 Endocrinologic and Metabolic Drugs Advisory Committee Intarcia PowerPoint Presentation", "Other", "Presentation", "2024-07-31T04:00:00Z", 2024, 7, "2024-07-31T04:00:00Z", null, "2024-07-31T20:10:45Z", null, 0, 0, "090000648661047a"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2021-N-0874-0089"], "units": {}, "query_ms": 0.4971390590071678, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}